{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:40:27Z","timestamp":1778661627620,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2004,8,9]],"date-time":"2004-08-09T00:00:00Z","timestamp":1092009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,8,9]],"date-time":"2004-08-09T00:00:00Z","timestamp":1092009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2004,10,1]]},"DOI":"10.1038\/sj.bmt.1704624","type":"journal-article","created":{"date-parts":[[2004,8,9]],"date-time":"2004-08-09T09:08:12Z","timestamp":1092042492000},"page":"627-636","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study"],"prefix":"10.1038","volume":"34","author":[{"given":"K-H","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S-J","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Seol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y-S","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W-K","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-S","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,8,9]]},"reference":[{"key":"BF1704624_CR1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood.V64.1.215.215","volume":"64","author":"HM Lazarus","year":"1984","unstructured":"Lazarus HM, Coccia PF, Herzig RH et al. Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients. Blood 1984; 64: 215\u2013220.","journal-title":"Blood"},{"key":"BF1704624_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0140-6736(80)90881-8","volume":"1","author":"RL Powles","year":"1980","unstructured":"Powles RL, Clink HM, Spence D et al. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet 1980; 1: 327\u2013329.","journal-title":"Lancet"},{"key":"BF1704624_CR3","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1056\/NEJM199310213291703","volume":"329","author":"NJ Chao","year":"1993","unstructured":"Chao NJ, Schmidt GM, Niland JC et al. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. N Engl J Med 1993; 329: 1225\u20131230.","journal-title":"N Engl J Med"},{"key":"BF1704624_CR4","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood.V65.6.1325.bloodjournal6561325","volume":"65","author":"HJ Deeg","year":"1985","unstructured":"Deeg HJ, Storb R, Thomas ED et al. Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. Blood 1985; 65: 1325\u20131334.","journal-title":"Blood"},{"key":"BF1704624_CR5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood.V71.2.293.293","volume":"71","author":"R Storb","year":"1988","unstructured":"Storb R, Deeg HJ, Fisher L et al. Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trails. Blood 1988; 71: 293\u2013298.","journal-title":"Blood"},{"key":"BF1704624_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1056\/NEJM198603203141201","volume":"314","author":"R Storb","year":"1986","unstructured":"Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729\u2013735.","journal-title":"N Engl J Med"},{"key":"BF1704624_CR7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1182\/blood.V80.2.560.560","volume":"80","author":"R Storb","year":"1992","unstructured":"Storb R, Pepe M, Deeg HJ et al. Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia. Blood 1992; 80: 560\u2013561.","journal-title":"Blood"},{"key":"BF1704624_CR8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1182\/blood.V68.1.119.119","volume":"68","author":"R Storb","year":"1986","unstructured":"Storb R, Deeg HJ, Farewell V et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 1986; 68: 119\u2013125.","journal-title":"Blood"},{"key":"BF1704624_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1365-2141.1989.tb04325.x","volume":"72","author":"R Storb","year":"1989","unstructured":"Storb R, Deeg HJ, Pepe M et al. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anemia: long-term follow-up of a controlled trial. Br J Haematol 1989; 72: 567\u2013572.","journal-title":"Br J Haematol"},{"key":"BF1704624_CR10","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood.V83.9.2749.2749","volume":"83","author":"R Storb","year":"1994","unstructured":"Storb R, Leisenring W, Deeg HJ et al. Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate\/cyclosporine vs methotrexate alone in patients given marrow grafts for severe aplastic anemia. Blood 1994; 83: 2749\u20132750.","journal-title":"Blood"},{"key":"BF1704624_CR11","first-page":"137","volume":"6","author":"M Mrsi\u00e6","year":"1990","unstructured":"Mrsi\u00e6 M, Labar B, Bogdani\u00e6 V et al. Combination of cyclosporin and methotrexate for prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 1990; 6: 137\u2013141.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704624_CR12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/sj.bmt.1700745","volume":"19","author":"T Ruutu","year":"1997","unstructured":"Ruutu T, Niederwieser D, Gratwohl A, Apperley JF . A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Bone Marrow Transplant 1997; 19: 759\u2013764.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704624_CR13","first-page":"155","volume":"16","author":"A Bacigalupo","year":"1965","unstructured":"Bacigalupo A, Tedone E, Isaza A et al. CMV-antigenemia after allogeneic bone marrow transplantation: correlation of CMV-antigen positive cell numbers with transplant-related mortality. Bone Marrow Transplant 1965; 16: 155\u2013161.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704624_CR14","first-page":"113","volume":"7","author":"J Aschan","year":"1991","unstructured":"Aschan J, Ringd\u00e9n O, Sundberg B et al. Methotrexate combined with cyclosporine A decreases graft-versus-host disease, but increases leukemia relapse compared to monotherapy. Bone Marrow Transplant 1991; 7: 113\u2013119.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704624_CR15","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1046\/j.1365-2141.2002.03748.x","volume":"118","author":"J-H Lee","year":"2002","unstructured":"Lee J-H, Lee K-H, Lee J-H et al. Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide. Br J Haematol 2002; 118: 1087\u20131094.","journal-title":"Br J Haematol"},{"key":"BF1704624_CR16","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl. 1","key":"BF1704624_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/stem.5530040710","volume":"4","author":"KM Sullivan","year":"1986","unstructured":"Sullivan KM . Acute and chronic graft-versus-host disease in man. Int J Cell Cloning 1986; 4 (Suppl. 1): 42\u201393.","journal-title":"Int J Cell Cloning"},{"key":"BF1704624_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255\u2013267.","journal-title":"Ann Intern Med"},{"key":"BF1704624_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/sj.bmt.1704147","volume":"32","author":"K-H Lee","year":"2003","unstructured":"Lee K-H, Lee J-H, Choi S-J et al. Monthly prospective analysis of hematopoietic chimerism after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2003; 32: 423\u2013431.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704624_CR20","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood.V91.9.3503","volume":"91","author":"P Zikos","year":"1998","unstructured":"Zikos P, Van Lint MT, Frassoni F et al. Low transplant mortality in allogeneic bone marrow transplantation for acute myeloid leukemia: a randomized study of low-dose cyclosporin vs low-dose cyclosporin and low-dose methotrexate. Blood 1998; 91: 3503\u20133508.","journal-title":"Blood"},{"key":"BF1704624_CR21","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V95.5.1572.005k12_1572_1579","volume":"95","author":"F Locatelli","year":"2000","unstructured":"Locatelli F, Zecca M, Rondelli R et al. Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial. Blood 2000; 95: 1572\u20131579.","journal-title":"Blood"},{"key":"BF1704624_CR22","first-page":"1690","volume":"96","author":"F Locatelli","year":"2000","unstructured":"Locatelli F, Bruno B, Zecca M et al. Cyclosporin A and short-term methotrexate vs cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO\/EBMT randomized trial. Blood 2000; 96: 1690\u20131697.","journal-title":"Blood"},{"key":"BF1704624_CR23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood.V77.1.201.201","volume":"77","author":"M van Marwijk Kooy","year":"1991","unstructured":"van Marwijk Kooy M, van Prooijen HC, Moes M et al. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial. Blood 1991; 77: 201\u2013205.","journal-title":"Blood"},{"key":"BF1704624_CR24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/sj.bmt.1701955","volume":"24","author":"K-H Lee","year":"1999","unstructured":"Lee K-H, Lee J-H, Choi SJ et al. Randomized comparison of two different schedules of granulocyte colony-stimulating factor administration after allogeneic bone marrow transplantation. Bone Marrow Transplant 1999; 24: 591\u2013599.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704624_CR25","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood.V77.7.1423.1423","volume":"77","author":"A Bacigalupo","year":"1991","unstructured":"Bacigalupo A, Van Lint MT, Occhini D et al. Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia. Blood 1991; 77: 1423\u20131428.","journal-title":"Blood"},{"key":"BF1704624_CR26","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/sj.bmt.1704224","volume":"32","author":"S-J Choi","year":"2003","unstructured":"Choi S-J, Lee K-H, Lee J-H et al. Peri-engraftment clinical abnormalities following allogeneic hematopoietic cell transplantation: a retrospective review of 216 patients. Bone Marrow Transplant 2003; 32: 809\u2013813.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704624_CR27","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood.V74.6.2252.2252","volume":"74","author":"Y Morishima","year":"1989","unstructured":"Morishima Y, Morishita Y, Tanimoto M et al. Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. Blood 1989; 74: 2252\u20132256.","journal-title":"Blood"},{"key":"BF1704624_CR28","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood.V75.12.2459.2459","volume":"75","author":"K Atkinson","year":"1990","unstructured":"Atkinson K, Horowitz MM, Gale RP et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990; 75: 2459\u20132464.","journal-title":"Blood"},{"key":"BF1704624_CR29","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJM198106183042507","volume":"304","author":"PL Weiden","year":"1981","unstructured":"Weiden PL, Sullivan KM, Flournoy N et al. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981; 304: 1529\u20131533.","journal-title":"N Engl J Med"},{"key":"BF1704624_CR30","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood.V73.6.1720.1720","volume":"73","author":"KM Sullivan","year":"1989","unstructured":"Sullivan KM, Weiden PL, Storb R et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989; 73: 1720\u20131728.","journal-title":"Blood"},{"key":"BF1704624_CR31","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1046\/j.1365-2141.2001.03002.x","volume":"114","author":"S Brunet","year":"2001","unstructured":"Brunet S, Urbano-Ispizua A, Ojeda E et al. Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies. Br J Haematol 2001; 114: 544\u2013550.","journal-title":"Br J Haematol"},{"key":"BF1704624_CR32","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1182\/blood.V98.13.3569","volume":"98","author":"G Soci\u00e9","year":"2001","unstructured":"Soci\u00e9 G, Clift RA, Blaise D et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. Blood 2001; 98: 3569\u20133574.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704624","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704624.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704624.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:04:03Z","timestamp":1648076643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,9]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,10,1]]}},"alternative-id":["BF1704624"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704624","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,9]]},"assertion":[{"value":"27 January 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}